Accordingly, both deletion and inhibition of hepatocyte-DRP1 activity in a preventative manner protected mice from high-fat diet-induced hepatic steatosis, insulin resistance and even body weight gain (Steffen et al. 2022). This evidence concerns the gene DNM1L and fatty liver disease.